JAIME CASH: Open Payments
NPI 1932763851 · BLOOMINGTON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$266 in 10 payments from 7 companies in 2025. Trend: 2023 $42 · 2024 $335 · 2025 $266
Food & beverage: $266
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $131 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: COBENFY, AUSTEDO XR, Jornay PM, VRAYLAR, UZEDY, CAPLYTA, SPRAVATO, TRINTELLIX.
Industry payments across IL — which companies pay providers there.
